Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;32(3):71-80.
doi: 10.3109/07357907.2013.876646.

Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?

Affiliations
Review

Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?

Lan Dai et al. Cancer Invest. .

Abstract

Sphingosine 1-phosphate (S1P) is an important signaling regulator involved in tumor progression in multiple neoplasms. However, the role of S1P in the pathogenesis of ovarian cancer remains unclear. Herein, we summarize recent advances in understanding the impact of S1P signaling in ovarian cancer progression. S1P, aberrantly produced in ovarian cancer patients, is involved in the regulation of key cellular processes that contribute to ovarian cancer initiation and progression. Moreover, agents that block the S1P signaling pathway inhibit ovarian cancer cell growth or induce apoptosis. Hence, current evidence suggests that S1P may become a potential molecular target for ovarian cancer therapy.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback